Investigating feasibility and efficacy of a virtual UNSW Lifestyle Clinic exercise physiologist intervention for people with hypertension: a pilot randomised controlled trial

A/Prof Xiaoqi Feng0 sites60 target enrollmentJanuary 27, 2022

Overview

No summary available.

Registry

who.int

Start Date

January 27, 2022

End Date

TBD

Last Updated

4 years ago

Study Type

Interventional

Sex

All

Sponsor

A/Prof Xiaoqi Feng

•be 18 years of age or older;
•diagnosed with hypertension and recent clinic systolic blood pressure greater than or equal to 130 mmHg and/or diastolic blood pressure greater than or equal to 80 mmHg;
•willing to wear wrist\-based blood pressure device for seven consecutive days at baseline and after 3 months;
•willing to undergo initial exercise tests by an Exercise Physiologist to determine eligibility;
•have access to a smartphone and the internet and feel comfortable to use it to download an App for use with a blood\-pressure device, complete online assessments, and join online video consultations with an Accredited Exercise Physiologist;
•no plan to change medications;
•have a personal weighing bathroom scale; and
•independently ambulant for 200m (be confident to walk 200m or around the block unassisted).

•significant alcohol or drug use;
•pregnancy (or planned pregnancy);
•unstable cardiovascular, respiratory and neurological disorders; established chronic kidney disease (eGFR \<60ml/kg/1\.73m2\); known arrhythmias (irregular heart rhythms); known vascular aneurysm; implanted electrical devices (e.g. cardiac pacemakers or defibrillators); severe or untreated mental health illnesses (including eating disorders); active cancer or requiring treatment for cancer; other health conditions, (e.g. orthopaedic or neuromuscular limitations) or hospital admissions within the last 6 months that would make it difficult or unsafe to participate in the exercise sessions at home safely. prior mastectomy (breast removal);
•wrist circumference \>22cm and upper arm circumference \>64 cm because of the BP device size;
•participation in any other behaviour change program or clinical trial that may interfere with the outcomes of this study, e.g. weight loss, physical activity or drug;
•unable to speak English (a translator is not available) or give written informed consent;
•allergy to the silicone material from the BP device.